NF-κB signaling and NF-κB subunit p65 regulate CXCR4 expression in breast cancer cells and neuroblastoma37,38, and acetylation of p65 at lysine 310 (K310) regulates its DNA-binding activity and target gene transcription39,40. This evidence concerns the gene NFKB1 and breast cancer.